Literature DB >> 22127832

Increased markers of oxidative stress in autistic children of the Sultanate of Oman.

Musthafa M Essa1, Gilles J Guillemin, Mostafa I Waly, Marwan M Al-Sharbati, Yahya M Al-Farsi, Faruck L Hakkim, Amanat Ali, Mohammed S Al-Shafaee.   

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder of early childhood, and an enumeration about its etiology and consequences is still limited. Oxidative stress-induced mechanisms are believed to be the major cause for ASD. In this study 19 autistic and 19 age-matched normal Omani children were recruited to analyze their degree of redox status and a prewritten consent was obtained. Blood was withdrawn from subjects in heparin-coated tube, and plasma was separated. Plasma oxidative stress indicators such as nitric oxide (NO), malondialdehyde (MDA), protein carbonyl, and lactate to pyruvate ratio were quantified using commercially available kits. A significant elevation was observed in the levels of NO, MDA, protein carbonyl, and lactate to pyruvate ratio in the plasma of Omani autistic children as compared to their age-matched controls. These oxidative stress markers are strongly associated with major cellular injury and manifest severe mitochondrial dysfunction in autistic pathology. Our results also suggest that oxidative stress might be involved in the pathogenesis of ASD, and these parameters could be considered as diagnostic markers to ensure the prevalence of ASD in Omani children. However, the oxidative stress-induced molecular mechanisms in ASD should be studied in detail.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127832     DOI: 10.1007/s12011-011-9280-x

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  18 in total

1.  Impaired lipid metabolism markers to assess the risk of neuroinflammation in autism spectrum disorder.

Authors:  Hanan Qasem; Laila Al-Ayadhi; Geir Bjørklund; Salvatore Chirumbolo; Afaf El-Ansary
Journal:  Metab Brain Dis       Date:  2018-03-22       Impact factor: 3.584

2.  Necrosis is increased in lymphoblastoid cell lines from children with autism compared with their non-autistic siblings under conditions of oxidative and nitrosative stress.

Authors:  Penelope A E Main; Philip Thomas; Adrian Esterman; Michael F Fenech
Journal:  Mutagenesis       Date:  2013-07       Impact factor: 3.000

Review 3.  Oxidative Stress in Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Mona A El-Bana; Alexey A Tinkov; Khaled Saad; Maryam Dadar; Maha Hemimi; Anatoly V Skalny; Božena Hosnedlová; Rene Kizek; Joško Osredkar; Mauricio A Urbina; Teja Fabjan; Amira A El-Houfey; Joanna Kałużna-Czaplińska; Paulina Gątarek; Salvatore Chirumbolo
Journal:  Mol Neurobiol       Date:  2020-02-05       Impact factor: 5.590

4.  High KEAP1, NRF2 and Low HO-1 Serum Levels in Children with Autism.

Authors:  Hamza Ayaydin; İsmail Akaltun; İsmail Koyuncu; Hakim Çelİk; Adnan Kİrmİt; Hatice Takatak
Journal:  Noro Psikiyatr Ars       Date:  2020-09-21       Impact factor: 1.339

5.  Chemoprevention of Colonic Aberrant Crypt Foci by Novel Schiff Based Dichlorido(4-Methoxy-2-{[2-(Piperazin-4-Ium-1-Yl)Ethyl]Iminomethyl}Phenolate)Cd Complex in Azoxymethane-Induced Colorectal Cancer in Rats.

Authors:  Maryam Hajrezaie; Keivan Shams; Soheil Zorofchian Moghadamtousi; Hamed Karimian; Pouya Hassandarvish; Mozhgan Emtyazjoo; Maryam Zahedifard; Nazia Abdul Majid; Hapipah Mohd Ali; Mahmood Ameen Abdulla
Journal:  Sci Rep       Date:  2015-07-23       Impact factor: 4.379

6.  Autistic children exhibit decreased levels of essential Fatty acids in red blood cells.

Authors:  Sarah A Brigandi; Hong Shao; Steven Y Qian; Yiping Shen; Bai-Lin Wu; Jing X Kang
Journal:  Int J Mol Sci       Date:  2015-05-04       Impact factor: 5.923

7.  A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders.

Authors:  Ahmad Ghanizadeh; Ebrahim Moghimi-Sarani
Journal:  BMC Psychiatry       Date:  2013-07-25       Impact factor: 3.630

8.  Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study.

Authors:  R E Frye; R DeLatorre; H B Taylor; J Slattery; S Melnyk; N Chowdhury; S J James
Journal:  Transl Psychiatry       Date:  2013-03-05       Impact factor: 6.222

9.  Physical exercise and intermittent administration of lactulose may improve autism symptoms through hydrogen production.

Authors:  Ahmad Ghanizadeh
Journal:  Med Gas Res       Date:  2012-07-30

10.  Role of NAD(+), Oxidative Stress, and Tryptophan Metabolism in Autism Spectrum Disorders.

Authors:  Musthafa Mohamed Essa; Selvaraju Subash; Nady Braidy; Samir Al-Adawi; Chai K Lim; Tamilarasan Manivasagam; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2013-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.